Cardiotoxicity, the often-overlooked second leading cause of death in cancer patients, has
been associated with certain anticancer drugs. These drugs can induce cardiac damage …

Risk stratification in drug allergy implies that specific risk categories (eg, low, moderate, and
high) classify historical drug hypersensitivity reactions. These risk categories can be based …

Breast cancer is one of the most prevalent and diverse malignancies, and, with global cases
increasing, the need for biomarkers to inform individual sensitivity to chemotherapeutics has …

Management of adverse reactions induced by chemotherapy drug... : Current Opinion in
Allergy and Clinical Immunology Management of adverse reactions induced by chemotherapy …

Histamine receptor antagonists, which can bind to specific histamine receptors on target
cells, exhibit substantial therapeutic efficacy in managing a variety of histamine-mediated …

To gain a comprehensive overview of the landscape of clinical trials for the H1-receptor
antagonists (H1R antagonists) cetirizine, levocetirizine, loratadine, desloratadine, and …

Introduction: Chemotherapy drugs have been in our lives for a long time, and all agents
have the potential to develop hypersensitivity. Rapid drug desensitization is an option when …

Glucocorticoid receptor (GR) activation may promote metastasis in oestrogen receptor-
negative and triple-negative breast cancer (TNBC). However, the role of the GRβ isoform …

Background/Objectives: Gastric cancer (GC) is the leading cause of cancer-related deaths
worldwide. C118P, a microtubule inhibitor with anti-angiogenic and vascular-disrupting …

INTRODUCTION: Patients receiving taxanes are at risk for developing hypersensitivity
reactions (HSRs) primarily during first and second lifetime exposures. Immediate HSRs …